Activating mutations of rhodopsin and other G protein-coupled receptors

Annual Review of Biophysics and Biomolecular Structure

Volumn 25, Issue , 1996, Pages 287-314

  Rao, Vikram R ^a   Oprian, Daniel D ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

constitutive activity; Schiff base; seven helix receptor; visual pigments

Indexed keywords

11 CIS RETINAL; GUANINE NUCLEOTIDE BINDING PROTEIN; OPSIN; RHODOPSIN; SCHIFF BASE;

COVALENT BOND; GENE MUTATION; HUMAN; NIGHT BLINDNESS; PHOTOACTIVATION; PRIORITY JOURNAL; RETINA DISEASE; RETINITIS PIGMENTOSA; REVIEW;

EID: 0029993990     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.bb.25.060196.001443     Document Type: Review

References (125)

1. Aho AC, Donner K, Hyden C, Larsen LO, Reuter T. 1988. Low retinal noise in animals with low body temperature allows high visual sensitivity. Nature 334:348-50
2. Deleted in proof.
3. Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S. 1991. G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the α- adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. USA 88: 11354-58
4. Anderson DE, Becktel WJ, Dahlquist FW. 1990. pH-Induced denaturation of protein: a single salt bridge contributes 3-5 kcal/mol to the free energy of folding of T4 lysozyme. Biochemistry 29:2403-8
5. Arnis S, Fahmy K, Hoffman KP, Sakmar TP. 1994. A conserved carboxylic acid group mediates light-dependent proton uptake and signalling by rhodopsin. J. Biol. Chem. 269: 23879-81
6. Bagley KA, Balogh-Nair V, Croteau AA, Dollinger G, Ebrey TG, et al. 1985. Fourier-transform infrared difference spectroscopy of rhodopsin and its photoproducts at low temperature. Biochemistry 24:6055-71
7. Baldwin JM. 1993. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12: 1693-703
8. Barlow HB. 1956. Retinal noise and absolute threshold. J. Opt. Soc. Am. 46:634-39
9. Barlow HB. 1988. The thermal limit to seeing. Nature 334: 296-97
10. Barlow RB, Birge RR, Kaplan E, Tallent JR. 1993. On the molecular origin of photoreceptor noise. Nature 366:64-66
11. Baylor DA, Lamb RD, Yau K-W. 1979. Responses of retinal rods to single photons. J. Physiol. 288: 613-34
12. Baylor DA, Matthews G, Yau K-W. 1980. Two components of electrical dark noise in toad retinal rod outer segments. J. Physiol. 309:591-621
13. Baylor DA, Nunn BJ, Schnapf JL. 1984. The photocurrent noise and spectral sensitivity of rods of the monkey Macaca fascicularis. J. Physiol. 357:575-607
14. Berson EL. 1993. Retinitis pigmentosa: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 34: 1659-76
15. Birge RR, Murray LP, Pierce BM, Akita H, Balogh-Nair V, et al. 1985. Two-photon spectroscopy of locked-11-cis-rhodopsin: evidence for a protonated Schiff base in a neutral protein binding site. Proc. Natl. Acad. Sci. USA 82:4117-21
16. Boone C, Davis NG, Sprague GF Jr. 1993. Mutations that alter the third cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype. Proc. Natl. Acad. Sci. USA 90:9921-25
17. Bownds D. 1967. Site of attachment of retinal in rhodopsin. Nature 216: 1178-81
18. Deleted in proof.
19. Cohen GB, Oprian DD, Robinson PR. 1992. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 31:12592-601
20. Cohen GB, Yang T, Robinson PR, Oprian DD. 1993. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 32:6111-15
21. Colley NJ, Cassil JA, Baker EK, Zuker CS. 1995. Defective intracellular transport is the molecular basis of rhodopsin-dependent retinal degeneration. Proc. Natl. Acad. Sci. USA 92:3070-74
22. Corson DW, Cornwall MC, MacNichol EF, Jin J, Johnson R, et. al. 1990. Sensitization of bleached rod photoreceptors by 11 cis-locked analogues of retinal. Proc. Natl. Acad. Sci. USA 87:6823-27
23. Cotecchia S, Exum S, Caron MG, Lefkowitz RJ. 1990. Regions of the α-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 87:2896-900
24. Defoe DM, Bok D. 1983. Rhodopsin chromophore exchanges among opsin molecules in the dark. Invest. Ophthalmol. Vis. Sci. 24:1211-26
25. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. 1991. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-88
26. Donnelly D, Findlay JBC. 1994. Seven-helix receptors: structure and modelling. Curr. Opin. Struct. Biol. 4:582-89
27. Doukas AG, Aton B, Callender RH, Ebrey TG. 1978. Resonance raman studies of bovine metarhodopsin I and metarhodopsin II. Biochemistry 17:2430-35
28. Dratz EA, Hargrave PA. 1983. The structure of rhodopsin and the rod outer segment disk membrane. Trends Biochem. Sci. 8:128-31
29. Dryja TP, Berson EL, Rao VR, Oprian DD. 1993. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nature Genet. 4: 280-83
30. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, et al. 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet. 7:396-401
31. Deleted in proof.
32. Emeis D, Kuhn H, Reichert J, Hoffman KP. 1982. Complex formation between metarhodopsin II and GTP-binding protein in bovine photoreceptor membranes leads to a shift of the photoproduct equilibrium. FEBS Lett. 143:29-34
33. Erikkson AE, Baase WA, Zheng X-J, Heinz DW, Blaker M, et al. 1992. Response of protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science 255:178-83
34. Fahmy K, Jager F, Beck M, Zvyaga TA, Sakmar TP, Siebert F. 1993. Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodopsin II: a Fourier-transform infrared spectroscopy study of site-directed mutants. Proc. Natl. Acad. Sci. USA 90: 10206-10
35. Fahmy K, Sakmar TP. 1993. Regulation of the rhodopsin-transducin interaction by a highly conserved carboxylic acid group. Biochemistry 32: 7229-36
36. Fahmy K, Siebert F, Sakmar TP. 1994. A mutant rhodopsin photoproduct with a protonated Schiff base displays an active-state conformation: a Fourier-transform infrared spectroscopy study. Biochemistry 33: 13700-5
37. Farahbakhsh ZT, Hideg K, Hubbell WL. 1993. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. Science 262:1416-19
38. Farahbakhsh ZT, Ridge KD, Khorana HG, Hubbell WL. 1995. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labelling study. Biochemistry 34:8812-19
39. Franke RR, Konig B, Sakmar TP, Khorana HG, Hofmann KP. 1990. Rhodopsin mutants that bind but fail to activate transducin. Science 250: 123-25
40. Franke RR, Sakmar TP, Graham RM, Khorana HG. 1992. Structure and function in rhodopsin: studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J. Biol. Chem. 267:14767-74
41. Gal A, Orth U, Baehr W, Schwinger E, Rosenberg T. 1994. Heterozygous missense mutation in the rod cGMP phosphodiesterase β-subunit gene in autosomal dominant stationary night blindness. Nature Genet. 7:64-68
42. Ganter UM, Longstaff C, Pajares MA, Rando RR, Siebert F. 1991. Fourier transform infrared studies of active-site-methylated rhodopsin: implications for chromophore-protein interaction, transducin activation, and the reaction pathway. Biophys. J. 59:640-44
43. Gat Y, Sheves M. 1993.A mechanism for controlling the pKa of the retinal protonated Schiff base in retinal proteins. A study with model compounds. J. Am. Chem Soc. 115: 3772-73
44. Deleted in proof.
45. Gilman AG. 1987. G-proteins: transducers of receptor generated signals. Annu. Rev. Biochem. 56:615-49
46. Govardhan CP, Oprian DD. 1994. Active site-directed inactivation of constitutively active mutants of rhodopsin. J. Biol. Chem. 269:6524-27
47. Han M, Smith SO. 1995. NMR constraints on the location of the retinal chromophore in rhodopsin and bathorhodopsin. Biochemistry 34: 1425-32
48. Hargrave PA, Hamm HE, Hofmann KP. 1993. Interaction of rhodopsin with the G-protein, transducin. BioEssays 15:43-50
49. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. 1993. Strucure and mechanism of the G protein coupled receptor kinases. J. Biol. Chem. 268: 23735-38
50. Jager F, Fahmy K, Sakmar TP, Sieben F. 1994. Identification of glutamic acid 113 as the schiff base proton acceptor in the metarhodopsin II photointermediate of rhodopsin. Biochemistry 33:10878-82
51. Jin J, Crouch RK, Corson DW, Katz BM, MacNichol EF, Cornwall MC. 1993. Non-covalent occupancy of the retinal-binding pocket of opsin diminishes bleaching adaptation of retinal cones. Neuron 11:513-22
52. Julius D, Livelli TJ, Jessell TM, Axel R. 1989. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244:1057-62
53. Kaushal S, Khorana HG. 1994. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33:6121-28
54. Keen TJ, Inglehearn CF, Lester DH, Bashir R, Jay M, et al. 1991. Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal binding site. Genomics 11:199-205
55. Kibelbek J, Mitchell DC, Beach JM, Litmann BJ. 1991. Functional equivalence of metarhodopsin II and the G activating form of photolyzed bovine rhodopsin. Biochemistry 30:6761-68
56. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ. 1992, Constitutive activation of the α-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267:1430-33
57. Konig B, Arendt A, McDowell JH, Kahlert M, Hargrave PA, Hofmann KP. 1989. Three cytoplasmic loops of rhodopsin interact with transducin. Proc. Natl. Acad. Sci. USA 86: 6878-82
58. Kosugi S, Shenker A, Mori T. 1994. Constitutive activation of cyclic AMP but not phosphatidylinositol signalling caused by four mutations in the sixth transmembrane helix of the human thyrotropin receptor. FEBS Lett. 356:291-94
59. Koutalos Y, Ebrey TG, Tsuda M, Odashima K, Lien T, et al. 1989. Regeneration of bovine and octopus opsins in situ with retinal and artificial retinals. Biochemistry 28:2732-39
60. Laue L, Chan W-Y, Hseuh AJ, Kudo M, Hsu SY, et al. 1995. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc. Natl. Acad Sci. USA 92: 1906-10
61. Lefkowitz RJ. 1993. Turned on to ill effect. Nature 365:603-4
62. Li T, Franson WK, Gordon JW, Berson EL, Dryja TP. 1995. Constitutive activation of phototransduction by K296E opsin is not the cause of photoreceptor degeneration. Proc. Natl. Acad. Sci. USA 92:3551-55
63. Lin SW, Sakmar TP, Franke RR, Khorana HG, Matthies RA. 1992. Resonance Raman microprobe spectroscopy of rhodopsin mutants: effect of substitutions in the third transmembrane helix. Biochemistry 31: 5105-11
64. Liri T, Herzmark P, Nakamoto J, van Dop C, Bourne HR. 1994. Rapid GDP release from G in patients with gain and loss of endocrine function. Nature 371:164-68
65. Longstaff C, Calhoon RD, Rando RR. 1986. Deprotonation of the Schiff base of rhodopsin is obligate in the activation of the G protein. Proc. Natl. Acad. Sci. USA 83: 4209-13
66. Matthews RG, Hubbard R, Brown PK, Wald G. 1963. Tautomeric forms of metarhodopsin. J. Gen. Physiol. 47:215-40
67. Matus-Leibovitch N, Nussenzveig DR, Gershengorn MC, Oron Y. 1995. Truncation of the thyrotropin-releasing hormone receptor carboxy tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells. J. Biol. Chem. 270:1041-47
68. Min KC, Zvyaga TA, Cypess AM, Sakmar TP. 1993. Characterization of mutant rhodopsin responsible for autosomal dominant retinitis pigmentosa: mutations on the cytoplasmic surface affect transducin activation. J. Biol. Chem. 268:9400-4
69. Nakayama TA, Khorana HG. 1991. Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. J. Biol Chem. 266: 4269-75
70. Nathans J. 1990. Determinants of visual pigment absorbance: identification of the retinylidenes Schiff's base counterion in bovine rhodopsin. Biochemistry 29:9746-52
71. Ohguro H, Palczewski K, Ericsson LH, Walsh KA, Johnson RS. 1993. Sequential phosphorylation of rhodopsin at multiple sites. Biochemistry 32:5718-24
72. Deleted in proof.
73. Oprian DD. 1992. The ligand-binding domain of rhodopsin and other G protein-linked receptors. J. Bioenerg. Biomembr. 24:211-17
74. Palczewski K, Benovic JL. 1991. G-protein coupled receptor kinases. Trends Biochem. Sci. 16:387-91
75. Palczewski K, Buczylko J, Kaplan MW, Polans AS, Crabb JW. 1991. Mechanism of rhodopsin kinase activation. J. Biol. Chem. 266:12949-55
76. Palczewski K, Rispoli G, Detwiler PB. 1992. The influence of arrestin (48K protein) and rhodopsin kinase on visual transduction. Neuron 8: 117-26
77. Palings I, Pardoen A, Van den Berg E, Winkel C, Lugtenberg J, Mathies RA. 1987. Assignment of fingerprint vibrations in the resonance raman spectra of rhodopsin, isorhodopsin, and bathorhodopsin: implications for the chromophore structure and environment. Biochemistry 24:2544-56
78. Parker EM, Ross EM. 1991. Truncation of the extended carboxyl-terminal domain increases the expression and regulatory activity of the avian β-adrenergic receptor. J. Biol. Chem. 266: 9987-96
79. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, et al. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649-51
80. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J. Clin. Endocrinol. Metab. 79:1785-89
81. Pei G, Samama, Lohse M, Wang M, Codina J, Lefkowitz RJ. 1994. A constitutively active mutant β-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl. Acad. Sci. USA 91:2699-702
82. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. 1994. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J. Clin. Endocrinol. Metab. 79:657-61
83. Portera-Cailliau C, Sung C-H, Nathans J, Adler R. 1994. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 91:974-78
84. Rao VR, Cohen GB, Oprian DD. 1994. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367: 639-42
85. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S. 1993. Constitutively active mutants of the α-adrenergic receptor. J. Biol. Chem. 268:16483-87
86. Resek JF, Farahbakhsh ZT, Hubbell WL, Khorana HG. 1993. Formation or the meta II photointermediate is accompanied by conformational changes in the cytoplasmic surface of rhodopsin. Biochemistry 32:12025-32
87. Resek JF, Farrens D, Khorana HG. 1994. Structure and function in rhodopsin: Covalent crosslinking of the rhodopsin (metarhodopsin II)-transducin complex-the rhodopsin cytoplasmic face links to the transducin a subunit. Proc. Natl. Acad. Sci. USA 91:7643-47
88. Rim J, Oprian DD. 1995. Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin. Biochemistry 34:11938-45
89. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, et al. 1993. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827-34
90. Robinson PR, Buczylko J, Ohguro H, Palczewski K. 1994. Opsins with mutations at the site of chromophore attachment constitutively activate transducin but are not phosphorylated by rhodopsin kinase. Proc. Natl. Acad. Sci. USA 91:5411-15
91. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD. 1992. Constitutively active mutants of rhodopsin. Neuron 9:719-25
92. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, et al. 1995. Genetic alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol Metab. 80:1347-51
93. Sakmar TP, Franke RR, Khorana HG. 1989. Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc. Natl. Acad. Sci. USA 86:309-13
94. Sakmar TP, Franke RR, Khorana HG. 1991. The role of the retinylidene Schiff base counterion in determining wavelength absorbance and Schiff base pK . Proc. Natl. Acad. Sci. USA 88:3079-83
95. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. 1993. A mutation-induced activated state of the β-adrenergic receptor. J. Biol. Chem. 268: 4625-36
96. Schertler GFX, Cilla C, Henderson R. 1993. Projection structure of rhodopsin. Nature 362:770-72
97. Schipani E, Kurse K, Juppner H. 1995. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100
98. Schleicher A, Kuhn H, Hofmann KP. 1989. Kinetics, binding constant, and activation energy of the 48 kDa protein-rhodopsin complex by extrametarhodopsin II. Biochemistry 28: 1770-75
99. Schoenlein RW, Peteanu LA, Mathies Ra, Shank CV. 1991. The first step in vision: femtosecond isomerization of rhodopsin. Science 254: 412-15
100. Sealfon SC, Chi L, Ebersole BJ, Radic V, Zhang D, et al. 1995. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT receptor. J. Biol. Chem. 270:16683-88
101. Seckler B, Rando RR. 1989. Schiffbase deprotonation is mandatory for light-dependent rhodopsin phosphorylation. Biochem. J. 264:489-93
102. Shenker A, Laue L, Kosugi S, Merendino J Jr, Minegishi T, Cutler GB Jr. 1993. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-54
103. Shi W, Osawa S, Dickerson CD, Weiss ER. 1995. Rhodopsin mutants discriminate sites important for the activation of rhodospin kinase and transducin. J. Biol. Chem. 270: 2112-19
104. Sieving PA, Richards JE, Naarendorp F, Bingham EL, Scott K, Alpern M. 1995. Dark-light: model for nightblindness from the human rhodopsin Gly-90→Asp mutation. Proc Natl Acad Sci USA. 92:880-84
105. Smith SO, Palings I, Miley M, Courtin J, de Groot H, et al. 1990. Solid-state NMR studies of the mechanism of the opsin shift in the visual pigment rhodopsin. Biochemistry 29: 8158-64
106. Steinberg G, Ottolenghi M, Sheves M. 1993. pK of the protonated Schiff base of bovine rhodopsin: a study with artificial pigments. Biophys. J. 64:1499-502
107. Deleted in proof.
108. Strader CD, Fong TM, Tota MR, Underwood D. 1994. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:101-32
109. Strader CD, Sigal IS, Register RB, Candelore MR, Ronds E, Dixon RAF. 1987. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 84:4384-88
110. Sullivan JM, Scott KM, Falls HF, Richards JH, Sieving PA. 1993. A novel rhodopsin mutation at the retinal binding site (Lys296-Met) in ADRP. Invest. Ophthalmol. Vis. Sci. 34:1149
111. Sung C-H, Davenport CM, Nathans J, 1993. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. J. Biol. Chem. 268:26645-49
112. Sung C-H, Makino C, Baylor D, Nathans J. 1994. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photorecepror outer segment. J. Neurosci. 14:5818-33
113. Sung C-H, Schneider BG, Agarwal N, Papermaster DS, Nathans J. 1991. Functional heterogeneity of mutant rhodopsins responsible for retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88:8840-44
114. Surya A, Foster KW, Knox BE. 1995. Transducin activation by the bovine opsin apoprotein. J. Biol. Chem. 270:5024-31
115. Wald G. 1968. Molecular basis of visual excitation. Science 162: 230-39
116. Deleted in proof.
117. Weitz CJ, Nathans J. 1993. Rhodopsin activation: effects of the metarhodopsin I-metarhodopsin II equilibrium of neutralization or introduction of charged amino acids within putative transmembrane segments. Biochemistry 32:14176-82
118. Wilden U, Hall SW, Kuhn H. 1986. Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc. Natl. Acad. Sci USA 83:1174-78
119. Deleted in proof.
120. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, et al. 1994. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol. 45:165-70
121. Zhukovsky EA, Oprian DD. 1989. Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science 246:928-30
122. Zhukovsky EA, Robinson PR, Oprian DD. 1991. Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore. Science 251:558-60
123. Zhukovsky EA, Robinson PR, Oprian DD. 1992. Changing the location of the Schiff base counterion in rhodopsin. Biochemistry 31:10400-5
124. Zvyaga TA, Fahmy K, Sakmar TP. 1994. Characterization of rhodopsin-transducin interaction: a mutant rhodopsin photoproduct with a protonated Schiff base activates transducin. Biochemistry 33:9753-61
125. Zvyaga TA, Min KC, Beck M, Sakmar TP. 1993. Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition. J. Biol. Chem. 268:4661-67 (Corr: J. Biol. Chem. 1994, 269: 13056)